A review of the literature pertaining to the neurobehavioral pharmacology of abusable drugs, this is the only book to survey each of the eleven classes of addictive drugs from the perspectives of neurological, behavioral, and clinical pharmacology. Designed to serve as a companion text to the DSM-IV manual, the Handbook provides comprehensive information about each drug and drug class having abuse potential with respect to their pharmaceutical mechanisms and actions.

This book could not have been conceptualized or published 20 years ago. Indeed, it is doubtful that we could have organized the material for this handbook 10 years ago. Over the last 20 years, however, the painstaking efforts of many clinical researchers working with a variety of resistive psychopathologies have resulted in specific psychotherapies and pharmacotherapies that are effective with a significant propor tion of patients, at least for some of the disorders. Much clinical research remains to be carried out in the forthcoming decades. But now that we are nearing the 21st century, at least some statement about efficacy can be made. In 1967, Gordon Paul succinctly stated that the ultimate goal of treatment outcome research is to determine "What treatment, by whom, is most effective for this individual with that specific problem, and under which set of circumstances" (p. 111). At that time, empirical evaluations of psychosocial and pharmacologic treatments were few and far between. Methodological strategies for determining treatment effectiveness were also in the formative stage, as exemplified by introduc tion of control groups that received inactive interventions (i. e., placebo) and the relatively recent practice of comparing two or more treatments in addition to placebo. In the almost three decades since Paul's oft-quoted dictum, both the quantity and the quality of treatment outcome research with adults have increased dramati cally."

Since the publication of the first edition in 1991, there has been substantial progress in our understanding of the etiology and associated features of domestic violence. As in the first edition, this book elucidates and highlights the complex multidisciplinary issues facing clinicians who work with family violence cases. Each chapter combines two illustrative cases with a broader discussion of the issues that are encountered by clinicians working with families that engage in abuse or neglect.

During the past decade, a dramatic increase in research and clinical interest has risen in child abuse and neglect. This recent growth in awareness isdue at leastpartly to thealarmingstatisticsdocumentingthe incidence of child maltreatment. Almost one million children are re ported to be abused and neglected each year, and many experts believe that this figure underestimates the true incidence. Indeed, recentsurveys suggest that almost 1. 5 million children are the targets of domestic vio lence every year. A significantproportion of these children die as a func tion of this maltreatment, whereas theremaindersuffera variety ofshort and long-term deleterious medicaland psychosocial consequences. Child maltreatment is a universal problem that has precipitated a mobilization of effort from a variety of disciplines, including psychology, medicine, psychiatry, social work, sociology, and criminology. Particular attention has been directed toward the prevention and treatment of childabuse and neglect. Such endeavors require the screen ing of large groups in order to identify families that are at high-risk for engaging in such behavior. Delineating those characteristics that differ entiate high- from low-risk families and children is one of the obvious priorities for researchers and clinicians in the future. This book, there fore, carefully considers the status of research on risk factors of abuse and neglect in children. Adduced data undoubtedly will have practical value for subsequent intervention efforts."

It is generally acknowledged that the most cost-effective means of curtailing alcohol and drug abuse is prevention. Providing interventions to at-risk individuals before they develop serious problems with substance use is the most important component of the "war on drugs." Fortunately, the past decade has seen a dramatic increase in the quantity and quality of scientific research on those areas crucial to the advancement of prevention science.
This book compiles a tremendous amount of information about prevention which has accumulated in recent years. Documenting these accomplishments and setting the stage for future efforts comprise the focus of this book.
"Prevention and Societal Impact of Drug and Alcohol Abuse" is divided into four parts. Part I contains introductory chapters addressing current issues in prevention science and characteristics of abusable substances. Part II includes chapters on the historical contexts of substance abuse and the deleterious health consequences of alcohol and other drugs. Part III focuses on the impact of drug and alcohol abuse on society. Included are chapters on alcohol and drug abuse and driving, infectious illness, disability, managed care, the criminal justice system and adolescents and adults, sale and distribution, the media, and community responses. Part IV consists of chapters on prevention in specific settings and with certain populations.

It is generally acknowledged that the most cost-effective means of curtailing alcohol and drug abuse is prevention. Providing interventions to at-risk individuals before they develop serious problems with substance use is the most important component of the "war on drugs." Fortunately, the past decade has seen a dramatic increase in the quantity and quality of scientific research on those areas crucial to the advancement of prevention science.
This book compiles a tremendous amount of information about prevention which has accumulated in recent years. Documenting these accomplishments and setting the stage for future efforts comprise the focus of this book.
"Prevention and Societal Impact of Drug and Alcohol Abuse" is divided into four parts. Part I contains introductory chapters addressing current issues in prevention science and characteristics of abusable substances. Part II includes chapters on the historical contexts of substance abuse and the deleterious health consequences of alcohol and other drugs. Part III focuses on the impact of drug and alcohol abuse on society. Included are chapters on alcohol and drug abuse and driving, infectious illness, disability, managed care, the criminal justice system and adolescents and adults, sale and distribution, the media, and community responses. Part IV consists of chapters on prevention in specific settings and with certain populations.

This book could not have been conceptualized or published 20 years ago. Indeed, it is doubtful that we could have organized the material for this handbook 10 years ago. Over the last 20 years, however, the painstaking efforts of many clinical researchers working with a variety of resistive psychopathologies have resulted in specific psychotherapies and pharmacotherapies that are effective with a significant propor tion of patients, at least for some of the disorders. Much clinical research remains to be carried out in the forthcoming decades. But now that we are nearing the 21st century, at least some statement about efficacy can be made. In 1967, Gordon Paul succinctly stated that the ultimate goal of treatment outcome research is to determine "What treatment, by whom, is most effective for this individual with that specific problem, and under which set of circumstances" (p. 111). At that time, empirical evaluations of psychosocial and pharmacologic treatments were few and far between. Methodological strategies for determining treatment effectiveness were also in the formative stage, as exemplified by introduc tion of control groups that received inactive interventions (i. e. , placebo) and the relatively recent practice of comparing two or more treatments in addition to placebo. In the almost three decades since Paul's oft-quoted dictum, both the quantity and the quality of treatment outcome research with adults have increased dramati cally.

Scarcely a day passes without the media detailing some form of human aggression, whether it be on its grandest scale in the form of war, random bombings and shootings in the streets, torture in a prison camp, murder by gangs, wife abuse resulting in the murder of the husband, or the physical abuse of children, sometimes resulting in their death. Frequently perpetrators of human aggression, when arrested and tried in court, resort to a psychiatric defense. But are all such aggressors indeed appropriately psychiatric patients? And if so, what are their particular diagnoses and how do these relate to aggression? Also of concern is aggression directed against self, as evidenced in the rising incidence of suicide among young people or the self-mutilation of patients suffering from certain personality disorders. Both violence directed outward and aggression toward oneself pose considerable challenges to clinical management, whether in the therapist's office or in the inpatient unit. Although we have not been able to find successful deterrents to aggression, a sizeable body of evidence does exist, certainly of a descriptive nature. Such data for psychiatric patients are scattered, however, and can be found in literatures as diverse as the biological, ethological, epidemiological, legal, philosophical, psychological, psychiatric, and crimi nological. Therefore, given the increased frequency with which mental health professionals encounter cases of violence in their day-to-day work, we believed it important that existing data be adduced in one comprehensive volume.

A review of the literature pertaining to the neurobehavioral pharmacology of abusable drugs, this is the only book to survey each of the eleven classes of addictive drugs from the perspectives of neurological, behavioral, and clinical pharmacology. Designed to serve as a companion text to the DSM-IV manual, the Handbook provides comprehensive information about each drug and drug class having abuse potential with respect to their pharmaceutical mechanisms and actions.

During the past decade, a dramatic increase in research and clinical interest has risen in child abuse and neglect. This recent growth in awareness isdue at leastpartly to thealarmingstatisticsdocumentingthe incidence of child maltreatment. Almost one million children are re ported to be abused and neglected each year, and many experts believe that this figure underestimates the true incidence. Indeed, recentsurveys suggest that almost 1. 5 million children are the targets of domestic vio lence every year. A significantproportion of these children die as a func tion of this maltreatment, whereas theremaindersuffera variety ofshort and long-term deleterious medicaland psychosocial consequences. Child maltreatment is a universal problem that has precipitated a mobilization of effort from a variety of disciplines, including psychology, medicine, psychiatry, social work, sociology, and criminology. Particular attention has been directed toward the prevention and treatment of childabuse and neglect. Such endeavors require the screen ing of large groups in order to identify families that are at high-risk for engaging in such behavior. Delineating those characteristics that differ entiate high- from low-risk families and children is one of the obvious priorities for researchers and clinicians in the future. This book, there fore, carefully considers the status of research on risk factors of abuse and neglect in children. Adduced data undoubtedly will have practical value for subsequent intervention efforts."

Since the publication of the first edition in 1991, there has been substantial progress in our understanding of the etiology and associated features of domestic violence. As in the first edition, this book elucidates and highlights the complex multidisciplinary issues facing clinicians who work with family violence cases. Each chapter combines two illustrative cases with a broader discussion of the issues that are encountered by clinicians working with families that engage in abuse or neglect.

The past 20 years have seen the emergence of family violence as one of the most critical problems facing society. The alarming incidence figures of abuse and neglect directed toward family members justify this atten tion. For example, over 1 million children are thought to be abused and neglected each year. Similarly, almost 2 million women are victims of wife battering each year. Annual rates of elderly mistreatment are thought to be as high as 32 per 1000 population. Accurate epidemiologi cal data only now are being compiled on more recently recognized forms of mistreatment, such as psychological abuse, ritualistic abuse of chil dren, and child witnessing of adult violence. The pervasiveness of do mestic mistreatment makes it a priority for clinicians and researchers alike. For clinicians, intrafamilial violence represents a formidable chal lenge with respect to assessment and treatment. The etiology of abuse and neglect is multidetermined. There are numerous pathways in the development of family violence, and these interact and converge in a nonlinear fashion. The consequences of family violence are equally com plex and divergent. Victims of mistreatment can display a variety of physical injuries and psychological disturbances. No single psychiatric syndrome or symptom constellation has been consistently implicated in any form of family mistreatment. The perpetrators of family violence are equally heterogeneous in their clinical presentations. Illustrative dys functions in perpetrators include skill deficits, substance abuse, mental illness, and impulse-control disorders."

There was a time when abnormal child psychology was the stepchild of abnormal psychology, with perhaps one or two chapters in an entire advanced textbook devoted to children. Given the explosive amount of new research on child development in general since the 1980s, "stepchild" is obviously no longer a valid characterization. Indeed, in the last 15 years, many new journals devoted to childhood problems have made their appearance on library bookshelves. The first edition of this book was assembled in an effort to integrate the empirical and clinical literatures and show the advanced undergraduate and beginning graduate student the breadth and depth of our existing knowledge about the disorders that manifest themselves early in development. Now, since its publication in 1995, a great deal more work has been done.
This revised and expanded second edition includes much new material from the first edition authors and from several new ones, all respected experts in the field.
Part I offers an overview. It outlines:
*historical developments with documentation of the neglect and abuse that children suffered at the hands of society well into the 20th century;
*developmental psychopathology as a theoretical framework to guide research and clinical efforts;
*psychophysiological determinants of behavior, with special attention focused on childhood autism, and attention deficit and antisocial conduct disorders;
*theoretical, methodological, and practical considerations involved in determining investigatory paths including sampling, design selection, measurement, data analysis, and pragmatics; and
*the reactions of children, families, and society to complex and diverse child health problems.
Part II addresses assessment and treatment issues. It discusses:
*behavioral treatment of childhood disorders and multiple case examples of commonly used techniques;
*new developments in pharmacological treatment and sound guidelines for the consideration of pharmacotherapy; and
*formulations and a review of preventive interventions.
Part III examines specific disorders of childhood and adolescence. It discusses:
*anxiety disorders, affective and mood disorders, mental retardation, autism, specific developmental disorders, conduct disorder, attention-deficit hyperactivity disorder (ADHD), and eating disorders;
*psychological aspects of pediatric disorders--interventions tailored to the needs of the child and family to maximize adaptation and recovery; and
*substance use disorders--ranging from models emphasizing social influences to those focusing on biological vulnerabilities.
Each chapter in Part III has an identical structure--"clinical description, causes, course, familial contributions, psychological and genetic influences, current treatments, summary"--and includes numerous case illustrations.